Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
How to Develop a National Formulary Based on the WHO Model Formulary - A Practical Guide
(2004; 45 pages) View the PDF document
Table of Contents
View the documentAbbreviations
Open this folder and view contents1 INTRODUCTION
Open this folder and view contents2 OVERVIEW OF THE NATIONAL FORMULARY PROCESS
Open this folder and view contents3 DEVELOPING THE PRELIMINARY INFORMATION SECTION
Open this folder and view contents4 DEVELOPMENT OF THERAPEUTIC INFORMATION AND MONOGRAPHS USING THE WHO MODEL FORMULARY
Open this folder and view contents5 ADDITIONAL SOURCES OF INFORMATION
Open this folder and view contents6 DEVELOPING SPECIFIC INFORMATION SECTIONS
Open this folder and view contents7 PRODUCTION, DISTRIBUTION AND IMPLEMENTATION
Open this folder and view contents8 EVALUATION
Open this folder and view contents9 REVIEW AND UPDATE
View the documentREFERENCES
 

How to Develop a National Formulary Based on the WHO Model Formulary - A Practical Guide


World Health Organization
2004

Authors

Richard Laing1 (Editor)

Klara Tisocki2

With contributions from: Douglas E. Ball2, Joe Collier3, Dinesh K. Mehta4, Rachel S. M. Ryan4, Andrea Tarr3,

The text was reviewed by: Jude Nwokike5, Rachel Ryan4, Khalid H.M. Said6, Wong Wai See7, Robert S. Summers8, Monika Zweygarth8

1 Department of Essential Drugs and Medicines Policy, World Health Organization, Geneva Switzerland

2 Faculty of Pharmacy, Kuwait University, Kuwait City, Kuwait

3 Editorial Committee, British National Formulary, Royal Pharmaceutical Society of Great Britain, London, United Kingdom

4 Drug and Therapeutics Bulletin, London, United Kingdom

5 Centre for Pharmaceutical Management, Management Sciences for Health, Inc (MSH), Windhoek, Namibia

6 Directorate General of Pharmacy, Federal Ministry of Health, Khartoum, Sudan

7 Department of Pharmaceutical Services, Ministry of Health, Bandar Seri Begawan, Brunei

8 MEDUNSA School of Pharmacy, Pretoria, South Africa


© World Health Organization, 2003

All rights reserved.

Publications of the World Health Organization can be obtained from Marketing and Dissemination, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to Publications, at the above address (fax: +41 22 791 4806; email: permissions@who.int).

The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.

The World Health Organization does not warrant that the information contained in this publication is complete and correct and shall not be liable for any damages incurred as a result of its use.

 

to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: November 5, 2014